• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Low prevalence of pulmonary embolism among patients with syncope

byAngela ZhangandAnees Daud
February 7, 2018
in Cardiology, Emergency, Imaging and Intervention, Public Health, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Based on this retrospective cohort study from multiple countries, the prevalence of pulmonary embolism among patients presenting to the emergency department (ED) with syncope was low at <1%.

2. Given the low probability of pulmonary embolism in patients with syncope, adopting a routine protocol for excluding PE in these patients is discouraged due to the risk of false-positive results and overtreatment.

Evidence Rating Level: 2 (Good)

Study Rundown: Pulmonary embolism (PE) is considered an important and serious cause of syncope. However, studies evaluating the presence of PE in patients presenting to the ED with syncope disagree on its prevalence, citing statistics ranging from less than 1.5% to as high as 17%. This study used administrative databases from four countries to evaluate the presence of PE in patients presenting to the ED, and found that rates of PE diagnosis ranged from 0.06% to 0.55% in all patients presenting with syncope, versus 0.15% to 2.10% in hospitalized patients with syncope.

Because the authors used administrative databases, they likely missed a small number of patients presenting with syncope. However, these results discourage the consideration of PE as a differential diagnosis for all patients presenting with syncope, because doing so could lead to false-positive results, overtreatment, and increased health care costs. Future investigation of prevalence stratified based on sex, age, comorbidities, and integration with risk stratification strategies would be insightful.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis

Relevant Reading: Overdiagnosis of pulmonary embolism by pulmonary CT angiography.

In-Depth [retrospective cohort]: This study used administrative databases from Canada, Denmark, Italy, and the United States to determine the prevalence of PE at presentation to the ED and at hospital discharge, as defined by ICD-9 and ICD-10 codes. The study found the rate of PE diagnosis to range from 0.06% to 0.55% in all patients presenting to the ED with syncope, and from 0.15% to 2.10% in the subset who was subsequently hospitalized. Furthermore, the authors completed two sensitivity analyses: (1) PE diagnosed within 90 days of follow-up, and (2) worst-case scenario of all venous thromboembolisms considered to result in PE, finding a prevalence of 0.14% to 0.83% in all patients and 0.35% to 2.63% for hospitalized patients for the former, and 0.30% to 1.37% in all patients and 0.75% to 3.86% in hospitalized patients for the latter.

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pulmonary embolismsyncopevenous thromboembolism
Previous Post

Hot tea consumption associated with increased esophageal cancer risk in high-risk individuals

Next Post

Systemic inflammatory response syndrome criteria may be more sensitive than quick sequential organ failure assessment for predicting mortality in patients with suspected infection

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Hematology

Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis

May 20, 2025
#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation
StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025
Next Post
Corticosteroids improve outcomes in treatment of community-acquired pneumonia

Systemic inflammatory response syndrome criteria may be more sensitive than quick sequential organ failure assessment for predicting mortality in patients with suspected infection

Preoperatively diagnosed patent foramen ovale linked to increased perioperative stroke risk

Factors contributing to parents providing alcohol sips to adolescents

Fetal alcohol spectrum disorders likely to be vastly underdiagnosed in US

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transcranial ultrasound stimulation may modulate acute heat pain perception
  • Large language models (LLMs) performed poorly in navigating early clinical diagnostic uncertainty
  • 2 Minute Medicine Rewind April 20, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.